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INTRODUCTION
Neurosarcoidosis occurs in approximately 5% of 
patients with sarcoidosis. Most cases manifest as 
cranial mononeuropathies, peripheral neuropathies 
or encephalopathy. Neuroendocrine dysfunction is 
more rarely seen. We present a case of hypopituitarism 
as a manifestation of neurosarcoidosis. 
METHODS
A 64 year old male with a history of neurosarcoidosis 
with associated hydrocephalous and seizures 
presented with a transient left facial droop and 
encephalopathy. He was hypothermic with a 
temperature of 90.4F and bradycardic. Initial lab 
studies showed an elevated serum sodium level of 
150. CT scan of the head showed no infarct and 
infectious workup was unremarkable. Of note, he 
was recently weaned off mycophenolate mofetil and 
was maintained on prednisone 17.5mg daily. MRI of 
the brain showed dural enhancement with areas of 
chronic ischemia. Further endocrine testing revealed 
low levels of the following: TSH 0.12, LH<1.2, FSH 
0.6, testosterone<5, ACTH <5. Water deprivation 
testing was done due to persistent hypernatremia 
and was diagnostic for diabetes insipidus.
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RESULTS
Based on his presentation, a neurosarcoidosis  
flare with infiltration of the hypothalamic-pituitary 
access and central dysregulation was suspected. 
He was started on stress dose steroids, levothyroxine, 
desmopressin and mycophenolate mofetil with 
improvement of symptoms. 
CONCLUSION
Neurosarcoidosis can present in a variety of ways; 
including hypothalamic disturbances in about 2-8% 
of patients and it is important for providers to have 
a high clinical suspicion in order to identify the 
serious hormonal disturbances associated with it. 
Flares of neurosarcoidosis are especially common 
when weaning patients off immunosuppressants, 
such as in this case. 
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